THE NORTH CENTRAL CANCER TREATMENT GROUP

北中癌症治疗小组(NCCTG)成立于 区域集团，但现在拥有国家成员资格。它是由 主要是服务于癌症需求的社区诊所 通过提供访问新的和 有希望的临床研究治疗方法。NCCTG发球 生产高质量产品满足国家癌症计划的需要 与社区实践最相关的研究 设置在绝大多数癌症患者所在的地方 治疗过了。NCCTG对拟议拨款的具体目标 期间如下： 1.开展有意义且科学合理的癌症临床研究 研究方案。 2.制定高质量的临床工作新标准 研究试验，并以这种方式优化有效性 结果。 3.为了在规划中促进真正的多学科互动， 临床癌症研究的执行和解释 协议。这种互动将涉及内科、外科和 放射肿瘤学家、病理学家、统计学家、护士、数据 操作者以及其他相关的内科和外科医生 分专业和实验室科学家。 4.评估新的癌症治疗方法的适用性和 社区层面的癌症控制方法，在那里大多数癌症 这个国家的病人都得到了管理。 5.培养最有效率、最具互补性和 社区诊所之间的非竞争性互动， 综合性癌症中心，以及国家级合作团体。 6.拓展我们的研究视野，超越对 通过探索包括癌症在内的癌症控制领域 检测和筛查、症状治疗和营养 支持。

The North Central Cancer Treatment Group (NCCTG) was founded at a regional group but now has national membership. It is composed predominantly of community clinics that serve the needs of cancer patients within their regions by providing access to new and hopeful clinical research treatment approaches. The NCCTG serves the needs of the National Cancer Program by producing high quality research that will be most relevant to the community practice setting where the overwhelming majority of cancer patients are treated. The specific aims of the NCCTG over the proposed grant period are the following: 1. To conduct meaningful and scientifically sound clinical cancer research protocols. 2. To set new standards of high quality in the conduct of clinical research trials and in this manner to optimize the validity of results. 3. To foster true multidisciplinary interaction in the planning, execution, and interpretation of clinical cancer research protocols. This interaction will involve medical, surgical and radiation oncologists, pathologists, statisticians, nurses, data handlers, as well as other pertinent medical and surgical subspecialties and laboratory scientists. 4. To evaluate the applicability of new cancer treatment and cancer control approaches at the community level where most cancer patients in this country are managed. 5. To develop the most productive, complimentary and noncompetitive inter-action between community clinics, comprehensive cancer center, and national cooperative groups. 6. To expand our research horizons beyond definitive care of the cancer itself by exploring areas of cancer control including cancer detection and screening, symptomatic management, and nutritional support.